Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,616,882
in 14 filings, $3.0M under 10b5-1 plans

Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-11 Schundler Russell General Counsel Grant or award +104,167 361,679
2023-01-11 Schundler Russell General Counsel Grant or award · Stock Option (Right to Buy) −133,547 133,547
2023-01-03 JEFFS ROGER Chief Executive Officer Exercise or conversion +15,807 207,249
2023-01-03 JEFFS ROGER Chief Executive Officer Exercise or conversion · Restricted Stock Unit −15,807 0
2022-10-03 JEFFS ROGER Chief Executive Officer Exercise or conversion +47,423 207,250
2022-10-03 JEFFS ROGER Chief Executive Officer Exercise or conversion · Restricted Stock Unit −47,423 15,807
2022-08-31 Moomaw Scott Chief Commercial Officer Grant or award +2,160 $4.90 $11K 9,810
2022-08-31 JEFFS ROGER Chief Executive Officer Grant or award +993 $4.90 $5K 116,007
2022-08-31 Kaseta Michael Chief Financial Officer Grant or award +1,927 $4.90 $9K 29,877
2022-08-31 Lippe Robert A Chief Operations Officer Grant or award +1,918 $4.90 $9K 98,026
2022-08-31 Schundler Russell General Counsel Grant or award +2,166 $4.90 $11K 224,912

Page 39 of 39 · 771 trades